Chitin Whisker-Enhanced Hyaluronic Acid Cell Scaffold and Preparation Method Thereof

    公开(公告)号:US20220081492A1

    公开(公告)日:2022-03-17

    申请号:US17106194

    申请日:2020-11-30

    IPC分类号: C08B37/08 C12M1/12

    摘要: Provided are a chitin whisker-enhanced hyaluronic acid cell scaffold and a preparation method thereof. Components of the cell scaffold include chitin whiskers and cross-linked hyaluronic acid. The chitin whisker-enhanced hyaluronic acid cell scaffold is obtained by dispersing chitin whiskers into deionized water using ultrasound, followed by addition of hyaluronic acid and uniform mixing to obtain an aqueous solution, adjusting a pH value of the aqueous solution to be in a range of 4.0 to 6.0, subjecting the aqueous solution to a cross-linking reaction, dialyzing a reaction product in a phosphate buffer solution, and freeze drying a resulting product. The chitin whisker-enhanced hyaluronic acid cell scaffold and the preparation method thereof can increase a mechanical property and a resistance to degradation of a scaffold material and expand an application scope of hyaluronic acid cell scaffolds.

    COLLAGEN AND SODIUM HYALURONATE CROSS-LINKED COMPOSITE FILLER FOR INJECTION AND PREPARATION METHOD THEREOF

    公开(公告)号:US20240238479A1

    公开(公告)日:2024-07-18

    申请号:US18135733

    申请日:2023-04-17

    IPC分类号: A61L27/26

    摘要: The present disclosure provides a collagen and sodium hyaluronate cross-linked composite filler for injection and a preparation method thereof. The collagen and sodium hyaluronate cross-linked composite filler is obtained by a cross-linking reaction of collagen and sodium hyaluronate with a 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride/N-hydroxysuccinimide (EDC/NHS) cross-linking system. As the EDC/NHS is used as a cross-linking agent in the present disclosure, the resulting product has no biological toxicity, so that the injury caused by a final product to an injection site and the human body is reduced. Meanwhile, due to intramolecular and intermolecular cross-linking, the degradation rate of the collagen and the sodium hyaluronate is reduced, and the retention time of the two in the body is prolonged. Therefore, the collagen and sodium hyaluronate cross-linked composite filler for injection in the present disclosure can be used in plastic surgery in the medical industry.

    Gradient Injection Comprising a Mixture of Polymer Microspheres

    公开(公告)号:US20220064436A1

    公开(公告)日:2022-03-03

    申请号:US17197022

    申请日:2021-03-09

    IPC分类号: C08L67/04

    摘要: Provided is a gradient injection containing a mixture of polymer microspheres. The injection is a freeze-dried powder composed of a filler, cross-linked sodium hyaluronate microspheres, poly-L-lactic acid (PLLA) microspheres, and an excipient. The powder can be mixed with sterile water and then used for injection cosmetology. A triple gradient effectiveness is provided by mixing the filler, the cross-linked sodium hyaluronate microspheres, and the PLLA microspheres to improve the subcutaneous capacity of human skin and repair skin wrinkles, folds, scars, and aging. The gradient injection is also suitable for repairing large-volume facial fat loss without adverse reactions such as nodules and granulomas.

    Gel for Injection Containing Controlled Degradation Polyester Microspheres

    公开(公告)号:US20230067215A1

    公开(公告)日:2023-03-02

    申请号:US17539154

    申请日:2021-11-30

    摘要: The present invention provides a gel for injection containing controlled degradation polyester microspheres. The gel for injection consists of crosslinked sodium hyaluronate gel, non-crosslinked sodium hyaluronate gel, polyester microspheres wrapped with hard fat and a balanced salt solution. The polyester microspheres are separated from water by means of wrapping and hydrophobic effect of the hard fat, and accordingly the present invention solve the problem that polyester materials are prone to degradation in gel. In the meantime, the hard fat has the characteristic of low melting point (melting point being 33° C.-39° C.), after the product is injected into human body, the hard fat is molten and separated under the action of human body temperature, and the wrapped polyester microspheres are released so that the microspheres can be degraded in the human body to achieve controlled degradation.

    Method for preparing cross-linked hyaluronic acid gel and cross-linked hyaluronic acid gel prepared by the same

    公开(公告)号:US11098168B2

    公开(公告)日:2021-08-24

    申请号:US16454089

    申请日:2019-06-27

    摘要: Related to is the field of polymer materials, and particularly related to are a method for preparing cross-linked hyaluronic acid gel and a cross-linked hyaluronic acid gel prepared by the method. Under an alkaline condition, a disulfide cross-linking agent is dropwise added into an alkaline solution of hyaluronic acid for cross-linking reaction, and after the reaction is completed, dialysis and freeze drying are carried out to obtain the cross-linked hyaluronic acid gel. A new disulfide cross-linking agent N,N-bis(acroloyl)cystamine is introduced, and it effectively solves degradation regulating problems of cross-linked hyaluronic acid; the disulfide bond ratio is controllable, which can effectively improve a cross-linking modification degree ratio in the cross-linked hyaluronic acid, thereby solving the problem of difficult degradation of highly cross-linked hyaluronic acid gel in the past. The cross-linked material has potential applications in aspects of drug carriers and tissue engineering scaffolds.

    Cyclical and continuous device and method for wet sieving of polysaccharide granules

    公开(公告)号:US12121907B1

    公开(公告)日:2024-10-22

    申请号:US18523848

    申请日:2023-11-29

    IPC分类号: B03B5/02 B01F27/90 B03B11/00

    CPC分类号: B03B5/02 B01F27/90 B03B11/00

    摘要: A cyclical and continuous device and method for wet sieving of polysaccharide granules are provided. The device includes a first dosing tank, a second dosing tank connected to the first dosing tank by a first circulation pump, a first suction filtration tank connected to the second dosing tank by a second circulation pump, and a second suction filtration tank connected to the first dosing tank by a third circulation pump. An overflow port provided on a side wall of the second dosing tank is higher than a feed port of the first dosing tank. A sieve of a mesh filter for coarse powder is disposed in the first dosing tank. A sieve of a mesh filter for fine powder is disposed in the second dosing tank. A stirring device is disposed in both the first dosing tank and the second dosing tank.